RPG Life Sciences rose 2.9% to Rs 252.30 at 9:21 IST on BSE after net profit jumped 84.6% to Rs 4.67 crore on 24.8% rise in net total income to Rs 73.21 crore in Q3 December 2015 over Q3 December 2014.
The result was announced after market hours yesterday, 2 February 2016.Meanwhile, the S&P BSE Sensex was down 228.29 points, or 0.93%, to 24,310.71
On BSE, so far 2,196 shares were traded in the counter as against an average daily volume of 44,205 shares in the past one quarter. The stock hit a high of Rs 254 and a low of Rs 247.50 so far during the day. The stock had hit a record high of Rs 360.60 on 3 December 2015. The stock had hit a 52-week low of Rs 98.60 on 2 February 2015.
The small-cap company has an equity capital of Rs 13.23 crore. Face value per share is Rs 8.
RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research-based pharmaceutical company producing a wide range of medicines.
Powered by Capital Market - Live News
